S'identifier

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.

Unlike nondepolarizing blockers, succinylcholine, a depolarizing blocker, has more severe adverse effects, including hyperkalemia, arrhythmia, postoperative muscle pain, increased intraocular pressure, and regurgitation of gastric content due to increased gastric pressure.

Adverse effects of directly acting agents like botulinum toxin and dantrolene include general muscle weakness and hepatotoxicity. Additionally, botulinum toxin can cause respiratory tract infections and loss of bladder control.

Lastly, centrally acting muscle relaxants, which affect the central nervous system or CNS, induce various symptoms of CNS depression. For example, tizanidine causes drowsiness, hypotension, dizziness, dry mouth, and hepatotoxicity, whereas diazepam causes anxiety, tremors, insomnia, and hallucinations. Avoiding high drug doses from being given to at-risk patients such as epileptic patients or pregnant women may help reduce the severity of the side effects.

Tags
Skeletal Muscle RelaxantsAdverse EffectsMuscle ParalysisNondepolarizing Neuromuscular BlockersHypotensionBaclofenSpastic ConditionsSuccinylcholineHyperkalemiaArrhythmiaPostoperative Muscle PainBotulinum ToxinDantroleneCNS DepressionTizanidineDiazepamHepatotoxicity

Du chapitre 7:

article

Now Playing

7.9 : Skeletal Muscle Relaxants: Adverse Effects

Skeletal Muscle Relaxants

302 Vues

article

7.1 : Jonction neuromusculaire et blocage

Skeletal Muscle Relaxants

2.6K Vues

article

7.2 : Classification des relaxants des muscles squelettiques

Skeletal Muscle Relaxants

2.3K Vues

article

7.3 : Bloqueurs neuromusculaires non dépolarisants (compétitifs) : mécanisme d’action

Skeletal Muscle Relaxants

1.2K Vues

article

7.4 : Bloqueurs neuromusculaires non dépolarisants (compétitifs) : actions pharmacologiques

Skeletal Muscle Relaxants

342 Vues

article

7.5 : Bloqueurs neuromusculaires non dépolarisants (compétitifs) : pharmacocinétique

Skeletal Muscle Relaxants

403 Vues

article

7.6 : Bloqueurs dépolarisants : mécanisme d’action

Skeletal Muscle Relaxants

995 Vues

article

7.7 : Bloqueurs dépolarisants : pharmacocinétique

Skeletal Muscle Relaxants

277 Vues

article

7.8 : Relaxants musculaires à action directe : dantrolène et toxine botulique

Skeletal Muscle Relaxants

596 Vues

article

7.10 : Relaxants des muscles squelettiques : utilisations thérapeutiques

Skeletal Muscle Relaxants

430 Vues

article

7.11 : Agents spasmolytiques : classification chimique

Skeletal Muscle Relaxants

824 Vues

article

7.12 : Comparaison des relaxants musculaires à action périphérique et centrale

Skeletal Muscle Relaxants

2.9K Vues

article

7.13 : Relaxants musculaires à action centrale : utilisations thérapeutiques

Skeletal Muscle Relaxants

549 Vues

JoVE Logo

Confidentialité

Conditions d'utilisation

Politiques

Recherche

Enseignement

À PROPOS DE JoVE

Copyright © 2025 MyJoVE Corporation. Tous droits réservés.